儿童肾囊肿的单基因病因:一项观察性队列研究
该单中心观察性队列纳入109例18岁以下肾囊肿患儿,采用多基因panel或外显子/基因组测序,81%受检者获得遗传学确诊,涉及14种疾病,以PKD1变异最常见(45%)。有家族史者诊断率更高,未确诊者更多为单侧囊肿。
要点
- 儿童肾囊肿经全面基因检测诊断率高达81%,病因涉及14种疾病。
- PKD1变异占45%,PKD2占7%,其他包括HNF1B/17q12缺失等。
- 有肾囊肿家族史者遗传诊断率更高(54% vs 11%,P=0.008)。
核心结论
- 在选择的儿童肾囊肿队列中,全面基因检测诊断率高,病因超出主要ADPKD/ARPKD基因,支持早期评估以改善诊断、预后和管理。
研究设计与样本
- 单中心观察性队列研究,纳入2020年1月至2024年6月109例18岁以下肾囊肿患者,采用靶向多基因或定制外显子/基因组测序panel。
主要发现
- 100例受检者中81例(81%)获得遗传学确诊,来自72个家庭(79%),涉及14种疾病。
- PKD1变异最常见(45%),PKD2占7%,HNF1B或17q12缺失占13%,次要ADPKD基因占11%(GANAB、NEK8、IFT140),单等位PKHD1占3%,双等位PKHD1占8%,综合征纤毛病基因占5%。
- 有肾囊肿家族史者遗传诊断更常见(54% vs 11%;P=0.008)。
- 未确诊者单侧囊肿更常见(26% vs 4%;P=0.53)。
临床怎么用
- 对儿童肾囊肿(包括无家族史者)应早期进行 comprehensive 基因检测以明确病因、指导预后和管理。
局限性
- 单中心选择偏倚,样本量有限,未确诊者单侧囊肿差异无统计学意义(P=0.53)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: In a cohort of children, 79% of families with kidney cysts had a monogenic diagnosis. Resolved cases were more likely to have a family history of kidney cysts and unresolved cases more often had unilateral cysts. Broad genetic testing revealed genetic diversity and informed prognosis and clinical management in childhood kidney cysts. BACKGROUND: Pediatric kidney cysts may indicate an underlying genetic disorder, yet the full spectrum of causes remains incompletely defined. With advances in genetic testing enabling broader evaluation, this study assessed the diagnostic utility of comprehensive genetic testing in a broad pediatric cohort with kidney cysts and characterized the underlying etiological diversity. METHODS: This observational cohort study included patients younger than 18 years enrolled between January 2020 and June 2024 at a single tertiary center. Genetic testing used targeted multigene or custom curated exome/genome sequencing panels, with segregation analysis when available. Eligible participants had at least two cysts without family history, one cyst with positive family history, or enlarged echogenic kidneys on prenatal ultrasound; those with congenital anomalies of the kidney and urinary tract associated with cysts were excluded. Clinical presentation was categorized as symptomatic, incidental, prenatal, or family screening. Primary outcomes were diagnostic yield and distribution of pathogenic variants. RESULTS: Among 109 patients (median age 7.6 years, 53% female), genetic testing identified a definitive diagnosis in 81 of 100 tested patients (81%) from 72 families (79%; 14 disorders). PKD1 variants were most common (45%), while PKD2 accounted for 7%. Other causes included HNF1B or 17q12 deletions (13%), minor autosomal dominant polycystic kidney disease genes (11%; GANAB, NEK8, IFT140 ), monoallelic PKHD1 (3%), and biallelic PKHD1 (8%), while syndromic ciliopathy genes accounted for 5%. A positive family history of cystic kidney disease was more common among patients with a genetic diagnosis (54% versus 11%; P = 0.008). Patients without an identified genetic diagnosis more often had unilateral cysts (26% versus 4%; P = 0.53). Diagnosis by clinical symptoms was the most genetically diverse category. CONCLUSIONS: Comprehensive genetic testing in pediatric kidney cysts achieved high diagnostic yield in a selected cohort and identified diverse causes beyond major autosomal dominant polycystic kidney disease/autosomal recessive polycystic kidney disease genes, supporting early evaluation to improve diagnostic accuracy, inform prognosis, and guide management, even in the absence of family history.
引用
- Bozkurt EG, Sheikh Najeeb M, Yang H, et al. Monogenic Etiologies of Kidney Cysts in the Pediatric Population: An Observational Cohort Study. Clin J Am Soc Nephrol. 2026. PMID: 41790507. doi:10.2215/CJN.0000001027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。